Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Evoke Pharma, Inc. (EVOK) had Weighted-Average Shares Outstanding (Diluted) of 2.55M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.75M |
|
$-1.57M |
|
$0.17M |
|
$3.58M |
|
$5.31M |
|
$-1.56M |
|
$-0.01M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.56M |
|
$-1.56M |
|
2.55M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.55M |
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$15.93M |
|
-- |
|
$0.13M |
|
$16.06M |
|
$11.62M |
|
-- |
|
$0.07M |
|
$11.69M |
|
$4.37M |
|
$4.37M |
|
$4.37M |
|
1.49M |
|
| Cash Flow Statement Financials | |
$-1.56M |
|
-- |
|
$0.03M |
|
$13.60M |
|
$12.06M |
|
$-1.54M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
-- |
|
1.14 |
|
95.53% |
|
-41.55% |
|
-41.55% |
|
-- |
|
-41.87% |
|
-41.87% |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.26 |
|
1.29 |
|
69.69 |
|
-35.91% |
|
-35.91% |
|
-9.78% |
|
-35.91% |
|
$2.93 |
|
$-0.61 |
|
$-0.61 |
|